Nanotechnologies for Anti-Inflammatory RNAi-Based Gene Silencing Strategies

ISSN: 1875-614X (Online)
ISSN: 1871-5230 (Print)

Volume 16, 3 Issues, 2017

Download PDF Flyer

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry

Formerly: Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

Claudiu T. Supuran
Neurofarba Department
University of Florence

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

Nanotechnologies for Anti-Inflammatory RNAi-Based Gene Silencing Strategies

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 9(3): 251-266.

Author(s): Gabriel Courties, Jessy Presumey, Isabelle Duroux-Richard, Christian Jorgensen and Florence Apparailly.

Affiliation: Inserm, U 844, INM, Hopital Saint Eloi, F-34295 Montpellier, France; Universite Montpellier1, UFR de Medecine, F-34000 Montpellier, France; CHU Lapeyronie, service Immuno-Rhumatologie, F-34000 Montpellier, France.


RNA interference (RNAi) is an endogenous process initiated by short double stranded RNAs, which results in sequence-specific posttranscriptional gene silencing. Since its discovery RNAi has become the most widely used experimental tool providing powerful and sequence-specific knockdown of protein expression to elucidate the function of genes. The possibility of blocking the expression of any protein carries huge expectations for potential therapeutic applications in a wide range of diseases. For clinical development, however, the use of RNAi-based therapeutics has to overcome major drawbacks and disadvantages, mainly targeted delivery and safety issues. This review summarizes the current status of progress made in the development of efficient in vivo silencing; focusing on both viral and non viral delivery strategies, and provides an overview of specifications for anti-inflammatory RNAi-based gene therapy in preclinical models of immune- mediated inflammatory disorders such as rheumatoid arthritis, skin disorders and inflammatory bowel diseases.


RNA interference, gene therapy, inflammation, nanoparticles, immunotherapy.

Purchase Online Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 9
Issue Number: 3
First Page: 251
Last Page: 266
Page Count: 16
DOI: 10.2174/1871523011009030251
Price: $58

Related Journals

Webmaster Contact: Copyright © 2016 Bentham Science